Lactobacillus Expressing Interferon-β Exacerbates Colitis
Author Information
Author(s): Adelle P. McFarland, Ram Savan, Wagage Sagie, Augustina Addison, Karthika Ramakrishnan, Megan Karwan, Tri Duong, Howard A. Young
Primary Institution: National Cancer Institute, Frederick, Maryland, USA
Hypothesis
Does localized delivery of interferon-β via Lactobacillus exacerbate experimental colitis?
Conclusion
The study found that Lactobacillus secreting interferon-β worsens colitis symptoms in mice.
Supporting Evidence
- IFNAR1−/− mice showed increased sensitivity to DSS-induced colitis.
- Colitic mice pretreated with La-IFN-β had increased levels of proinflammatory cytokines.
- Loss of IFNAR1 expression on dendritic cells correlated with exacerbation of colitis.
Takeaway
Researchers used a special bacteria to deliver a protein that usually helps with inflammation, but instead, it made the inflammation worse in mice.
Methodology
Mice were pretreated with Lactobacillus expressing interferon-β before being induced with colitis using DSS.
Potential Biases
Potential bias in the interpretation of results due to the specific model used.
Limitations
The study was conducted in a murine model, which may not fully replicate human conditions.
Participant Demographics
Mice used were A/J and C57BL/6 strains, aged 8-12 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website